Essential thrombocytosis and myocardial infarction in an aircrew member: Aeromedical concerns

Aviation Space and Environmental Medicine

Volumn 77, Issue 1, 2006, Pages 69-72

  Perrier, Eric ^a   Manen, Olivier ^a   Cinquetti, Gael ^a  

^a PERCY MILITARY HOSPITAL   (France)

Author keywords

Coronary artery disease; Essential thrombocytosis; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AIRPLANE CREW; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; FEMALE; FRANCE; HEART INFARCTION; HUMAN; INCIDENTAL FINDING; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIFESTYLE; MUTAGENESIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING; SPACE; ST SEGMENT ELEVATION; STENT; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOSIS; VEIN THROMBOSIS;

ADULT; AEROSPACE MEDICINE; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; MILITARY PERSONNEL; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; SMOKING; THROMBOCYTOSIS; WORK CAPACITY EVALUATION;

THROMBUS;

EID: 30644464350     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Barbui T, Barosi G, Gugliotta L, et al. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Haematology, the Italian Society of Experimental Haematology, and the Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89:215-32.
2. Blann A, Caine G, Bareford D. Abnormal vascular, platelet and coagulation markers in primary thrombocythemia are not reversed by treatments that reduce the platelet count. Platelets 2004; 15:447-9.
3. Harrison CN. Current trends in essential thrombocythemia. Br J Haematol 2002; 117:796-808.
4. Harvis LH. You're the flight surgeon: essential thrombocytosis. Aviat Space Environ Med 2004; 75:627-8.
5. Jacobson BF, Phillipides M, Malherbe M, Becker P. Risk factors for deep vein thrombosis in short-haul cockpit crews: a prospective study. Aviat Space Environ Med 2002; 73:481-4.
6. Landgraf H, Vanselow B, Schulte-Huermann D, et al. Economy class syndrome: rheology, fluid balance, and lower leg edema during a simulated 12-hour long distance flight. Aviat Space Environ Med 1994; 65:930-5.
7. Lebedeva EV, Yushkov BG, Chereshnev VA. Megakaryocytoposis under hypoxic conditions. Bull Exp Biol Med 2003; 136:554-6.
8. Pearson TC. The risk of thrombosis in essential thrombocythemia and polycythemia vera. Semin Oncol 2002; 29:16-21.
9. Possick SE, Barry M. Evaluation and management of the cardiovascular patient embarking on air travel. Ann Intern Med 2004; 141:148-54.
10. Schafer AI. Thrombocytosis. N Engl J Med 2004; 350:1211-9.
11. Schobersberger W, Fries D, Mittermayr M, et al. Changes of biochemical markers and functional test for clot formation during long-haul flights. Thromb Res 2002; 108:19-24.
12. Steurer M, Gastl G, Jedrzczak WW, et al. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile. Cancer 2004; 101:2239-46.